Navamedic ASA (FRA:N1A)

Market Cap	44.89M
Revenue (ttm)	46.03M
Net Income (ttm)	-3.23M
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	51.47
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	58
Open	1.880
Previous Close	1.880
Day's Range	1.840 - 1.880
52-Week Range	1.490 - 2.180
Beta	n/a
RSI	44.86
Earnings Date	Feb 12, 2026

About Navamedic ASA

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. The company’s product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic and propioni...

• Industry: Pharmaceutical Preparations
• Founded: 2002
• Employees: 42
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: N1A

Financial Performance

In 2024, Navamedic ASA's revenue was 531.44 million, an increase of 3.80% compared to the previous year's 512.00 million. Losses were -5.49 million, -59.92% less than in 2023.

Financial numbers in NOK